(in-person) courses and conferences effective July 1, 2021 and available COVID-19 online education and resources.
Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice 2021
This course is offered Live and Livestream
Course Directors: Halena M. Gazelka, M.D., Benjamin Lai, M.B., B.Ch., B.A.O. and Julie L. Cunningham, Pharm.D., R.Ph.
The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2021 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, opioid tapering and legal considerations, as well as medical and interventional alternatives to opioids. In addition, the course covers a broad range of issues, including opioid use disorder and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. This course includes lectures by experts in the field of pain medicine and opioid management as well as question and answer sessions.
- Learn the most up-to-date information regarding the appropriate use and management of opioids in clinical practice.
- Discuss the basics of opioid pharmacology, selection, and side effect management, along with evidence-based guidelines for opioid management, tapering, and legal considerations, and medical and interventional alternatives to opioids.
- Address opioid use disorder, difficult patient conversations and guidelines to standardize the practice of opioid prescribing.
This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including medical, surgical and outpatient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (nurse, pharmacist, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy.
Upon completion of this activity, participants should be able to:
- Review opioid practice updates and discuss how to implement a plan to appropriately monitor patients who chronically use opioids.
- Define methods to taper opioids using a team-based approach and the options for proper opioid disposal.
- Describe the use of methadone and buprenorphine in the management of chronic pain.
- Determine and optimize treatment for patients suffering from pain and comorbid depression/anxiety.
- Identify those with opioid use disorder and understand medication assisted therapy.
- Apply best practice for non-opioid adjuvants, interventional pain therapies, and alternative pain modalities as part of a comprehensive multimodal pain management plan.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Mayo Clinic is closely monitoring COVID-19 prevalence and may adjust live course attendance limits as necessitated by CDC, public health and other relevant guidelines. Attendees are asked to comply with all live course and conference guidelines.
All travel and lodging expenses are the sole responsibility of the individual registrant.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this Other activity (live and livestream) for a maximum of 18.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Pre-Course Session 1: Buprenorphine||1.50|
|Pre-Course Session 2: Naloxone||1.50|
|General Session - 15.50|
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 18.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.50 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared with ABIM through PARS.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 18.50 knowledge-based contact hours. Participants should only claim credit commensurate with the extent of their participation in the activity.
ACPE Universal Activity Number (UAN): JA0000238-0000-21-084-L01-P
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 18.50 ABIM
- 18.50 ACPE
- 18.50 AMA PRA Category 1 Credit™
- 18.50 ANCC
- 18.50 Attendance